{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:27:35Z","timestamp":1790357255008,"version":"4.1.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T00:00:00Z","timestamp":1297987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T00:00:00Z","timestamp":1297987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s11302-011-9216-0","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T14:07:04Z","timestamp":1297951624000},"page":"305-324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Pharmacochemistry of the platelet purinergic receptors"],"prefix":"10.1007","volume":"7","author":[{"given":"Kenneth A.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Deflorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpi","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Costanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"key":"9216_CR1","doi-asserted-by":"crossref","unstructured":"Coddou C, Yan Z, Obsil T, Huidobro-Toro JP, Stojilkovic SS (2011) Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev (in press)","DOI":"10.1124\/pr.110.003129"},{"key":"9216_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/pr.58.3.3","volume":"58","author":"M Abbracchio","year":"2006","unstructured":"Abbracchio M, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII. Update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281\u2013341","journal-title":"Pharmacol Rev"},{"key":"9216_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00249-008-0325-9","volume":"3","author":"B Marquez-Klaka","year":"2009","unstructured":"Marquez-Klaka B, Rettinger J, Nicke A (2009) Inter-subunit disulfide cross-linking in homomeric and heteromeric P2X receptors. Eur Biophys J 3:329\u2013338","journal-title":"Eur Biophys J"},{"key":"9216_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1124\/jpet.300.2.673","volume":"300","author":"S Brown","year":"2002","unstructured":"Brown S, Townsend-Nicholson A, Jacobson KA, Burnstock G, King BF (2002) Heteromultimeric P2X1\/2 receptors show a novel sensitivity to extracellular pH. J Pharmacol Exp Ther 300:673\u2013680","journal-title":"J Pharmacol Exp Ther"},{"key":"9216_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jmb.2004.06.092","volume":"342","author":"A Armaz","year":"2004","unstructured":"Armaz A, Sadtler S, Niculescu C, Rettinger J, Schmalzing G (2004) Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes. J Mol Biol 342:333\u2013343","journal-title":"J Mol Biol"},{"key":"9216_CR6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1471-4159.2004.02939.x","volume":"92","author":"A Nicke","year":"2005","unstructured":"Nicke A, Kerschensteiner D, Soto F (2005) Biochemical and functional evidence for heteromeric assembly of P2X1and P2X4 subunits. J Neurochem 92:925\u2013933","journal-title":"J Neurochem"},{"key":"9216_CR7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1124\/mol.54.6.989","volume":"54","author":"G Torres","year":"1998","unstructured":"Torres G, Haines W, Egan T, Voigt M (1998) Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel. Mol Pharmacol 54:989\u2013993","journal-title":"Mol Pharmacol"},{"key":"9216_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1124\/mol.109.058578","volume":"76","author":"RL Carter","year":"2009","unstructured":"Carter RL, Fricks IP, Barrett MO, Burianek LE, Zhou Y, Ko H, Das A, Jacobson KA, Lazarowski ER, Harden TK (2009) Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor. Mol Pharmacol 76:1341\u20131348","journal-title":"Mol Pharmacol"},{"key":"9216_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0014-2999(98)00976-5","volume":"367","author":"SS Wildman","year":"1999","unstructured":"Wildman SS, Brown SG, King BF, Burnstock G (1999) Selectivity of diadenosine polyphosphates for the rat P2X receptor subunits. Eur J Pharmacol 367:119\u2013123","journal-title":"Eur J Pharmacol"},{"key":"9216_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11302-005-0648-2","volume":"1","author":"SR Shaver","year":"2005","unstructured":"Shaver SR, Rideout J, Pendergast W, Douglass JG, Brown EG, Boyer JL, Patel RI, Redick CC, Jones AC, Picher M, Yerxa BR (2005) Structure\u2013activity relationships of dinucleotides: potent and selective agonists of P2Y receptors. Purinergic Signal 1:183\u2013191","journal-title":"Purinergic Signal"},{"key":"9216_CR11","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","volume":"25","author":"P Ciani","year":"2006","unstructured":"Ciani P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, Gelosa P, Guerrini U, Belcredito S, Cimino M, Sironi L, Tremoli E, Rovati GE, Martini C, Abbracchio MP (2006) The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor. EMBO J 25:4615\u20134627","journal-title":"EMBO J"},{"key":"9216_CR12","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1074\/jbc.273.4.2030","volume":"273","author":"J Jin","year":"1998","unstructured":"Jin J, Daniel JL, Kunapuli SP (1998) Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 273:2030\u20132034","journal-title":"J Biol Chem"},{"key":"9216_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/09537100410001682788","volume":"15","author":"MP Mahaut-Smith","year":"2004","unstructured":"Mahaut-Smith MP, Tolhurst G, Evans RJ (2004) Emerging roles for P2X1 receptors in platelet activation. Platelets 15:131\u2013144","journal-title":"Platelets"},{"key":"9216_CR14","first-page":"261","volume":"2","author":"N Dovlatova","year":"2008","unstructured":"Dovlatova N, Wijeyeratne YD, Fox SC, Manolopoulos P, Johnson AJ, White AE, Latif ML, Ralevic V, Heptinstall S (2008) Detection of P2Y14 protein in platelets and investigation of the role of P2Y14 in platelet function in comparison with the EP3 receptor. Thromb Haemost 2:261\u2013270","journal-title":"Thromb Haemost"},{"key":"9216_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jcp.22379","volume":"226","author":"HA Johnston-Cox","year":"2011","unstructured":"Johnston-Cox HA, Yang D, Ravid K (2011) Physiological implications of adenosine receptor-mediated platelet aggregation. J Cell Physiol 226:46\u201351","journal-title":"J Cell Physiol"},{"key":"9216_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1021\/cr0682195","volume":"108","author":"PG Baraldi","year":"2008","unstructured":"Baraldi PG, Tabrizi TA, Gessi S, Borea PA (2008) Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility. Chem Rev 108:238\u2013263","journal-title":"Chem Rev"},{"key":"9216_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-540-89615-9_3","volume":"193","author":"G Cristalli","year":"2010","unstructured":"Cristalli G, M\u00fcller CE, Volpini R (2010) Recent developments in adenosine A2A receptor ligands. Handb Exp Pharmacol 193:59\u201398","journal-title":"Handb Exp Pharmacol"},{"key":"9216_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2174\/187153008786848303","volume":"8","author":"J Ham","year":"2008","unstructured":"Ham J, Rees DA (2008) The adenosine A2b receptor: its role in inflammation. Endocr Metabol Imm Disorders\u2013Drug Targets 8:244\u2013254","journal-title":"Endocr Metabol Imm Disorders\u2013Drug Targets"},{"key":"9216_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1538-7836.2010.03769.x","volume":"4","author":"D Yang","year":"2010","unstructured":"Yang D, Chen H, Koupenova M, Carroll SH, Eliades A, Freedman JE, Toselli P, Ravid K (2010) A new role for the A2b adenosine receptor in regulating platelet function. J Thromb Haemost 4:817\u2013827","journal-title":"J Thromb Haemost"},{"key":"9216_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature08198","volume":"460","author":"T Kawate","year":"2009","unstructured":"Kawate T, Michel JC, Birdsong WT, Gouaux E (2009) Crystal structure of the ATP-gated P2X4 ion channel in the closed state. Nature 460:592\u2013598","journal-title":"Nature"},{"key":"9216_CR21","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1471-4159.2009.06035.x","volume":"4","author":"JA Roberts","year":"2009","unstructured":"Roberts JA, Valente M, Allsopp RC, Watt D, Evans RJ (2009) Contribution of the region Glu181 to Val200 of the extracellular loop of the human P2X1 receptor to agonist binding and gating revealed using cysteine scanning mutagenesis. J Neurochem 4:1042\u20131052","journal-title":"J Neurochem"},{"key":"9216_CR22","first-page":"437","volume":"3","author":"TE Webb","year":"1994","unstructured":"Webb TE, Simon J, Bateson AN, Barnard EA (1994) Transient expression of the recombinant chick brain P2y1 purinoceptor and localization of the corresponding. Cell Mol Biol (Noisy-le-grand) 3:437\u2013442","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"9216_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/35051599","volume":"409","author":"G Hollopeter","year":"2001","unstructured":"Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by anti-thrombotic drugs. Nature 409:202\u2013207","journal-title":"Nature"},{"key":"9216_CR24","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1021\/jm049914c","volume":"47","author":"S Costanzi","year":"2004","unstructured":"Costanzi S, Mamedova L, Gao ZG, Jacobson KA (2004) Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem 47:5393\u20135404","journal-title":"J Med Chem"},{"key":"9216_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10822-006-9054-2","volume":"20","author":"AA Ivanov","year":"2006","unstructured":"Ivanov AA, Costanzi S, Jacobson KA (2006) Defining the nucleotide binding sites of P2Y receptors using rhodopsin-based homology modeling. J Comput Aided Mol Des 20:417\u2013426","journal-title":"J Comput Aided Mol Des"},{"key":"9216_CR26","doi-asserted-by":"crossref","first-page":"C559","DOI":"10.1152\/ajpcell.00401.2004","volume":"3","author":"Z Ding","year":"2005","unstructured":"Ding Z, Tuluc F, Bandivadekar KR, Zhang L, Jin J, Kunapuli SP (2005) Arg333 and Arg334 in the COOH terminus of the human P2Y1 receptor are crucial for Gq coupling. Am J Physiol Cell Physiol 3:C559\u2013C567","journal-title":"Am J Physiol Cell Physiol"},{"key":"9216_CR27","doi-asserted-by":"publisher","first-page":"9340","DOI":"10.1523\/JNEUROSCI.2635-06.2006","volume":"26","author":"AK Filippov","year":"2006","unstructured":"Filippov AK, Choi RC, Simon J, Barnard EA, Brown DA (2006) Activation of P2Y1 nucleotide receptors induces inhibition of the M-type K+ current in rat hippocampal pyramidal neurons. J Neurosci 26:9340\u20139348","journal-title":"J Neurosci"},{"key":"9216_CR28","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1538-7836.2008.03039.x","volume":"8","author":"SJ Mundell","year":"2008","unstructured":"Mundell SJ, Barton JF, Mayo-Martin MB, Hardy AR, Poole AW (2008) Rapid resensitization of purinergic receptor function in human platelets. J Thromb Haemost 8:1393\u20131404","journal-title":"J Thromb Haemost"},{"key":"9216_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1538-7836.2006.01866.x","volume":"4","author":"DM Bourdon","year":"2006","unstructured":"Bourdon DM, Boyer JL, Mahanty S, Jacobson KA, Harden TK (2006) (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets. J Thromb Haemost 4:861\u2013868","journal-title":"J Thromb Haemost"},{"key":"9216_CR30","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1242\/jcs.060723","volume":"123","author":"SC Wolff","year":"2010","unstructured":"Wolff SC, Qi AD, Harden TK, Nicholas RA (2010) Charged residues in the C-terminus of the P2Y1 receptor constitute a basolateral-sorting signal. J Cell Sci 123:2512\u20132520","journal-title":"J Cell Sci"},{"key":"9216_CR31","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/jcb.20985","volume":"99","author":"E Belous","year":"2006","unstructured":"Belous E, Jones CM, Wakata A, Knox CD, Nicoud IB, Pierce J, Chari RS (2006) Mitochondrial calcium transport is regulated by P2Y1- and P2Y2-like mitochondrial receptors. J Cell Biochem 99:1165\u20131174","journal-title":"J Cell Biochem"},{"key":"9216_CR32","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1074\/jbc.M709266200","volume":"283","author":"RC Choi","year":"2008","unstructured":"Choi RC, Simon J, Tsim KW, Barnard EA (2008) Constitutive and agonist-induced dimerizations of the P2Y1 receptor: relationship to internalization and scaffolding. J Biol Chem 283:11050\u201311063","journal-title":"J Biol Chem"},{"key":"9216_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ddr.10169","volume":"58","author":"H Nakata","year":"2003","unstructured":"Nakata H, Yoshioka K, Saitoh O (2003) Hetero-oligomerization between adenosine A1 and P2Y1 receptors in living cells: formation of ATP-sensitive adenosine receptors. Drug Dev Res 58:340\u2013349","journal-title":"Drug Dev Res"},{"key":"9216_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1042\/BJ20070671","volume":"1","author":"D Ecke","year":"2008","unstructured":"Ecke D, Hanck T, Tulapurkar ME, Sch\u00e4fer R, Kassack M, Stricker R, Reiser G (2008) Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor. Biochem J 1:107\u2013116","journal-title":"Biochem J"},{"key":"9216_CR35","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1021\/jm970684u","volume":"41","author":"S Moro","year":"1998","unstructured":"Moro S, Guo D, Camaioni E, Boyer JL, Harden TK, Jacobson KA (1998) Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J Med Chem 41:1456\u20131466","journal-title":"J Med Chem"},{"key":"9216_CR36","doi-asserted-by":"publisher","first-page":"14639","DOI":"10.1074\/jbc.274.21.14639","volume":"274","author":"C Hoffmann","year":"1999","unstructured":"Hoffmann C, Moro S, Nicholas RA, Harden TK, Jacobson KA (1999) The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes. J Biol Chem 274:14639\u201314647","journal-title":"J Biol Chem"},{"key":"9216_CR37","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.bcp.2008.08.029","volume":"10","author":"K Hoffmann","year":"2008","unstructured":"Hoffmann K, Sixel U, Di Pasquale F, von K\u00fcgelgen I (2008) Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y12-receptor. Biochem Pharmacol 10:1201\u20131213","journal-title":"Biochem Pharmacol"},{"key":"9216_CR38","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1021\/bc900569u","volume":"21","author":"S De Castro","year":"2010","unstructured":"De Castro S, Maruoka H, Hong K, Kilbey SM, Costanzi S, Hechler B, Brown GG, Gachet C, Harden TK, Jacobson KA (2010) Functionalized congeners of P2Y1 receptor antagonists: 2-alkynyl (N)-methanocarba 2\u2032-deoxyadenosine 3\u2032, 5\u2032-bisphosphate analogues and conjugation to a polyamidoamine (PAMAM) dendrimer carrier. Bioconjug Chem 21:1190\u20131205","journal-title":"Bioconjug Chem"},{"key":"9216_CR39","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/science.1164772","volume":"322","author":"VP Jaakola","year":"2008","unstructured":"Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, IJzerman AP, Stevens RC (2008) The 2.6\u00a0angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322:1211\u20131217","journal-title":"Science"},{"key":"9216_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","volume":"25","author":"JA Ballesteros","year":"1995","unstructured":"Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure\u2013function relations in G protein-coupled receptors. Methods Neurosci 25:366\u2013428","journal-title":"Methods Neurosci"},{"key":"9216_CR41","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1124\/jpet.109.156687","volume":"331","author":"K Hoffmann","year":"2009","unstructured":"Hoffmann K, Baqi Y, Morena MS, Gl\u00e4nzel M, M\u00fcller CE, von K\u00fcgelgen I (2009) Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor. J Pharmacol Exp Ther 331:648\u2013655","journal-title":"J Pharmacol Exp Ther"},{"key":"9216_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejphar.2010.06.023","volume":"644","author":"Y Mao","year":"2010","unstructured":"Mao Y, Zhang L, Jin J, Ashby B, Kunapuli SP (2010) Mutational analysis of residues important for ligand interaction with the human P2Y12 receptor. Eur J Pharmacol 644:10\u201316","journal-title":"Eur J Pharmacol"},{"key":"9216_CR43","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1111\/j.1476-5381.1995.tb17215.x","volume":"116","author":"JL Boyer","year":"1995","unstructured":"Boyer JL, O\u2019Tuel J, Fischer B, Jacobson KA, Harden TK (1995) Potent agonist action of 2-thioether derivatives of adenine nucleotides at adenylyl cyclase-linked P2Y purinoceptors. Br J Pharmacol 116:2611\u20132616","journal-title":"Br J Pharmacol"},{"key":"9216_CR44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1124\/mol.105.014654","volume":"1","author":"Z Ding","year":"2006","unstructured":"Ding Z, Kim S, Kunapuli SP (2006) Identification of a potent inverse agonist at a constitutively active mutant of human P2Y12 receptor. Mol Pharmacol 1:338\u2013345","journal-title":"Mol Pharmacol"},{"key":"9216_CR45","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1182\/blood-2002-10-3027","volume":"10","author":"Z Ding","year":"2003","unstructured":"Ding Z, Kim S, Dorsam RT, Jin J, Kunapuli SP (2003) Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270. Blood 10:3908\u20133914","journal-title":"Blood"},{"key":"9216_CR46","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1111\/j.1538-7836.2008.03136.x","volume":"6","author":"I Algaier","year":"2008","unstructured":"Algaier I, Jakubowski JA, Asai F, von K\u00fcgelgen I (2008) Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor. J Thromb Haemost 6:1908\u20131914","journal-title":"J Thromb Haemost"},{"key":"9216_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.bjp.0703761","volume":"132","author":"A Sugidachi","year":"2001","unstructured":"Sugidachi A, Asai F, Yoneda K, Iwamura R, Ogawa T, Otsuguro K, Koike H (2001) Prasugrel metabolite: antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type Gi-linked P2T antagonist, CS-747. Br J Pharmacol 132:47\u201354","journal-title":"Br J Pharmacol"},{"key":"9216_CR48","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1538-7836.2005.01144.x","volume":"3","author":"M Hasegawa","year":"2005","unstructured":"Hasegawa M, Sugidachi A, Ogawa T, Isobe T, Jakubowski JA, Asai F (2005) Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor. Thromb Haemost 3:593\u2013598","journal-title":"Thromb Haemost"},{"key":"9216_CR49","doi-asserted-by":"publisher","first-page":"13987","DOI":"10.1074\/jbc.270.23.13987","volume":"270","author":"J Kim","year":"1995","unstructured":"Kim J, Wess J, van Rhee AM, Sh\u00f6neberg T, Jacobson KA (1995) Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor. J Biol Chem 270:13987\u201313997","journal-title":"J Biol Chem"},{"key":"9216_CR50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0026-895X(25)08783-8","volume":"49","author":"J Kim","year":"1996","unstructured":"Kim J, Jiang Q, Glashofer M, Yehle S, Wess J, Jacobson KA (1996) Glutamate residues in the second extracellular loop of the human A2a adenosine receptors are required for ligand recognition. Mol Pharmacol 49:683\u2013691","journal-title":"Mol Pharmacol"},{"key":"9216_CR51","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1021\/jm901647p","volume":"53","author":"V Katritch","year":"2010","unstructured":"Katritch V, Jaakola VP, Lane JR, Lin J, IJzerman AP, Yeager M, Kufareva I, Stevens RC, Abagyan R (2010) Structure-based discovery of novel chemotypes for adenosine A2A receptor antagonists. J Med Chem 53:1799\u20131809","journal-title":"J Med Chem"},{"key":"9216_CR52","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1021\/jm100240h","volume":"53","author":"J Carlsson","year":"2010","unstructured":"Carlsson J, Yoo L, Gao ZG, Irwin J, Shoichet B, Jacobson KA (2010) Structure-based discovery of adenosine A2A receptor ligands. J Med Chem 53:3748\u20133755","journal-title":"J Med Chem"},{"key":"9216_CR53","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bcp.2010.04.027","volume":"80","author":"M Kecsk\u00e9s","year":"2010","unstructured":"Kecsk\u00e9s M, Kumar TS, Yoo L, Gao ZG, Jacobson KA (2010) Novel Alexa Fluor-488 labeled antagonist of the A2A adenosine receptor: application to a fluorescence polarization-based receptor binding assay. Biochem Pharmacol 80:506\u2013511","journal-title":"Biochem Pharmacol"},{"key":"9216_CR54","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1021\/bc9001689","volume":"20","author":"Y Kim","year":"2009","unstructured":"Kim Y, Hechler B, Gao ZG, Gachet C, Jacobson KA (2009) PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors. Bioconjug Chem 20:1888\u20131898","journal-title":"Bioconjug Chem"},{"key":"9216_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/1098-2299(20000901)51:1<7::AID-DDR2>3.0.CO;2-W","volume":"51","author":"L Chen","year":"2000","unstructured":"Chen L, Hardwick JP, McPhie P, Sitkovsky M, Jacobson KA (2000) Purification and recognition of recombinant mouse P2X1 receptors expressed in a baculovirus system. Drug Dev Res 51:7\u201319","journal-title":"Drug Dev Res"},{"key":"9216_CR56","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1124\/mol.65.2.426","volume":"2","author":"GL Waldo","year":"2004","unstructured":"Waldo GL, Harden TK (2004) Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor. Mol Pharmacol 2:426\u2013436","journal-title":"Mol Pharmacol"},{"key":"9216_CR57","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1124\/mol.64.5.1210","volume":"5","author":"ET Bodor","year":"2003","unstructured":"Bodor ET, Waldo GL, Hooks SB, Corbitt J, Boyer JL, Harden TK (2003) Purification and functional reconstitution of the human P2Y12 receptor. Mol Pharmacol 5:1210\u20131216","journal-title":"Mol Pharmacol"},{"key":"9216_CR58","doi-asserted-by":"crossref","unstructured":"Deaglio S, Robson SC (2011) Ectonucleotidases as regulators of purinergic signaling in inflammation and thrombosis. Adv Pharmacol (in press)","DOI":"10.1016\/B978-0-12-385526-8.00010-2"},{"key":"9216_CR59","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.bjp.0707361","volume":"152","author":"SA Levesque","year":"2007","unstructured":"Levesque SA, Lavoie EG, Lecka J, Bigonnesse F, Sevigny J (2007) Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br J Pharmacol 152:141\u2013150","journal-title":"Br J Pharmacol"},{"key":"9216_CR60","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1021\/jm901851t","volume":"53","author":"Y Baqi","year":"2010","unstructured":"Baqi Y, Lee SY, Iqbal J, Ripphausen P, Lehr A, Scheiff AB, Zimmermann H, Bajorath J, M\u00fcller CE (2010) Development of potent and selective inhibitors of ecto-5\u2032-nucleotidase based on an anthraquinone scaffold. J Med Chem 53:2076\u20132086","journal-title":"J Med Chem"},{"key":"9216_CR61","doi-asserted-by":"publisher","unstructured":"Semianrio-Vidal L, van\u00a0Hesuden C, Mugesh G, Lazarowski ER (2011) Ebselen is a potent non-competitive inhibitor of extracellular nucleoside diphosphokinase. Purinergic Signal. doi:10.1007\/s11302-010-9203-x","DOI":"10.1007\/s11302-010-9203-x"},{"key":"9216_CR62","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0026-895X(25)09262-4","volume":"2","author":"W Beindl","year":"1996","unstructured":"Beindl W, Mitterauer T, Hohenegger M, Ijzerman AP, Nanoff C, Freissmuth M (1996) Inhibition of receptor\/G protein coupling by suramin analogues. Mol Pharmacol 2:415\u2013423","journal-title":"Mol Pharmacol"},{"key":"9216_CR63","doi-asserted-by":"publisher","first-page":"20644","DOI":"10.1074\/jbc.M109.083626","volume":"27","author":"P Krejci","year":"2010","unstructured":"Krejci P, Murakami S, Prochazkova J, Trantirek L, Chlebova K, Ouyang Z, Aklian A, Smutny J, Bryja V, Kozubik A, Wilcox WR (2010) NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells. J Biol Chem 27:20644\u201320653","journal-title":"J Biol Chem"},{"key":"9216_CR64","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/sj.bjp.0706453","volume":"147","author":"D Houston","year":"2006","unstructured":"Houston D, Ohno M, Nicholas RA, Jacobson KA, Harden TK (2006) [32P]2-iodo-N\n                           6-methyl-(N)-methanocarba-2\u2032-deoxyadenosine-3\u2032, 5\u2032-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors. Br J Pharmacol 147:459\u2013467","journal-title":"Br J Pharmacol"},{"key":"9216_CR65","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.1016\/j.bmcl.2005.08.104","volume":"15","author":"A El-Tayeb","year":"2005","unstructured":"El-Tayeb A, Griessmeier KJ, M\u00fcller CE (2005) Synthesis and preliminary evaluation of [3H]PSB-0413, a selective antagonist radioligand for platelet P2Y12 receptors. Bioorg Med Chem Lett 15:5450\u20135452","journal-title":"Bioorg Med Chem Lett"},{"key":"9216_CR66","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1476-5381.1994.tb13204.x","volume":"112","author":"X Bo","year":"1994","unstructured":"Bo X, Fischer B, Maillard M, Jacobson KA, Burnstock G (1994) Comparative studies on the affinities of ATP derivatives to P2X-purinoceptors in rat urinary bladder. Br J Pharmacol 112:1151\u20131159","journal-title":"Br J Pharmacol"},{"key":"9216_CR67","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/j.1538-7836.2009.03527.x","volume":"7","author":"JJJ van Giezen","year":"2009","unstructured":"van Giezen JJJ, Nilsson L, Berntsson P, Wissing BM, Giordanetto F, Tomlinson W, Greasley PJ (2009) Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation. J Thromb Haemost 7:1556\u20131565","journal-title":"J Thromb Haemost"},{"key":"9216_CR68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1476-5381.1996.tb15381.x","volume":"1","author":"JB Schachter","year":"1996","unstructured":"Schachter JB, Li Q, Boyer JL, Nicholas RA, Harden TK (1996) Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br J Pharmacol 1:167\u2013173","journal-title":"Br J Pharmacol"},{"key":"9216_CR69","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1517\/13543771003702424","volume":"20","author":"H Gunosewoyo","year":"2010","unstructured":"Gunosewoyo H, Kassiou M (2010) P2X purinergic receptor ligands: recently patented compounds. Expert Opin Ther Pat 20:625\u2013646","journal-title":"Expert Opin Ther Pat"},{"key":"9216_CR70","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1021\/jm020046y","volume":"45","author":"KA Jacobson","year":"2002","unstructured":"Jacobson KA, Jarvis MF, Williams M (2002) Perspective: purine and pyrimidine (P2) receptors as drug targets. J Med Chem 45:4057\u20134093","journal-title":"J Med Chem"},{"key":"9216_CR71","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0014-2999(99)00350-7","volume":"376","author":"BR Bianchi","year":"1999","unstructured":"Bianchi BR, Lynch KJ, Touma E, Niforatos W, Burgard EC, Alexander KM, Park HS, Yu H, Metzger R, Kowaluk E, Jarvis MF, van Biesen T (1999) Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol 376:127\u2013138","journal-title":"Eur J Pharmacol"},{"key":"9216_CR72","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/1098-2299(200004)49:4<253::AID-DDR4>3.0.CO;2-1","volume":"49","author":"SG Brown","year":"2000","unstructured":"Brown SG, King BF, Kim YC, Burnstock G, Jacobson KA (2000) Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors. Drug Dev Res 49:253\u2013259","journal-title":"Drug Dev Res"},{"key":"9216_CR73","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1476-5381.1994.tb17034.x","volume":"113","author":"JL Boyer","year":"1994","unstructured":"Boyer JL, Zohn IE, Jacobson KA, Harden TK (1994) Differential effects of P2-purinergic receptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y purinergic receptors. Br J Pharmacol 113:614\u2013620","journal-title":"Br J Pharmacol"},{"key":"9216_CR74","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/BF00168441","volume":"354","author":"H Whittenburg","year":"1996","unstructured":"Whittenburg H, B\u00fcltmann R, Pause B, Ganter C, Kurz G, Starke K (1996) P2-purinoceptor antagonists:II blockade of P2-purinoceptor subtypes and ecto-nuleotidase by compounds related to Evans blue and trypan blue. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 354:491\u2013497","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9216_CR75","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.2174\/1381612023392973","volume":"8","author":"G Lambrecht","year":"2002","unstructured":"Lambrecht G, Braun K, Damer M, Ganso M, Hildebrandt C, Ullmann H, Kassack MU, Nickel P (2002) Structure\u2013activity relationships of suramin and pyridoxal-5\u2032-phosphate derivatives as P2 receptor antagonists. Curr Pharm Des 8:2371\u20132399","journal-title":"Curr Pharm Des"},{"key":"9216_CR76","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/jm9904203","volume":"44","author":"YC Kim","year":"2001","unstructured":"Kim YC, Brown SG, Harden TK, Boyer JL, Dubyak G, King BF, Burnstock G, Jacobson KA (2001) Structure activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors. J Med Chem 44:340\u2013349","journal-title":"J Med Chem"},{"key":"9216_CR77","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1021\/jm980183o","volume":"41","author":"KA Jacobson","year":"1998","unstructured":"Jacobson KA, Kim YC, Wildman SS, Mohanram A, Harden TK, Boyer JL, King BF, Burnstock G (1998) A pyridoxine cyclic phosphate and its 6-axoaryl derivative selectively potentiate and antagonise activation of P2X1 receptors. J Med Chem 41:2201\u20132206","journal-title":"J Med Chem"},{"key":"9216_CR78","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/sj.bjp.0702876","volume":"128","author":"BF King","year":"1999","unstructured":"King BF, Liu M, Pintor J, Gualix J, Miras-Portugal MT, Burnstock G (1999) Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors. Br J Pharmacol 128:981\u2013988","journal-title":"Br J Pharmacol"},{"key":"9216_CR79","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0026-895X(24)13265-8","volume":"53","author":"C Virginio","year":"1998","unstructured":"Virginio C, Robertson G, Surprenant NRA (1998) Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3 and heteromeric P2X2\/3 receptors. Mol Pharmacol 53:969\u2013973","journal-title":"Mol Pharmacol"},{"key":"9216_CR80","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0028-3908(98)00158-0","volume":"38","author":"F Soto","year":"1999","unstructured":"Soto F, Lambrecht G, Nickel P, St\u00fchmer W, Busch AE (1999) Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors. Neuropharmacology 38:141\u2013149","journal-title":"Neuropharmacology"},{"key":"9216_CR81","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1021\/jm050301p","volume":"48","author":"H Ullmann","year":"2005","unstructured":"Ullmann H, Meis S, Hongwiset D, Marzian C, Wiese M, Nickel P, Communi D, Boeynaems JM, Wolf C, Hausmann R, Schmalzing G, Kassack MU (2005) Synthesis and structure\u2013activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency. J Med Chem 48:7040\u20137048","journal-title":"J Med Chem"},{"key":"9216_CR82","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/S0028-3908(00)00022-8","volume":"39","author":"J Rettinger","year":"2000","unstructured":"Rettinger J, Schmalzing G, Damer S, M\u00fcller G, Nickel P, Lambrecht G (2000) The suramin analogue NF279 is a novel and potent antagonist selective for the P2X1 receptor. Neuropharmacology 39:2044\u20132053","journal-title":"Neuropharmacology"},{"key":"9216_CR83","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.neuropharm.2004.11.003","volume":"48","author":"J Rettinger","year":"2005","unstructured":"Rettinger J, Braun K, Hochmann H, Kassack MU, Ullmann H, Nickel P, Schmalzing G, Lambrecht G (2005) Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist. Neuropharmacology 48:461\u2013468","journal-title":"Neuropharmacology"},{"key":"9216_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-005-1085-z","volume":"372","author":"S Horner","year":"2005","unstructured":"Horner S, Menke K, Hildebrandt C, Kassack MU, Nickel P, Ullmann H, Mahaut-Smith MP, Lambrecht G (2005) The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 372:1\u201313","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9216_CR85","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1016\/j.bmcl.2005.04.049","volume":"15","author":"S Jaime-Figueroa","year":"2005","unstructured":"Jaime-Figueroa S, Greenhouse R, Padilla F, Dillon MP, Gever JR, Ford APDW (2005) Discovery and synthesis of a novel and selective drug-like P2X1 antagonist. Bioorg Med Chem Lett 15:3292\u20133295","journal-title":"Bioorg Med Chem Lett"},{"key":"9216_CR86","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.drudis.2010.05.011","volume":"15","author":"KA Jacobson","year":"2010","unstructured":"Jacobson KA, Boeynaems JM (2010) P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today 15:570\u2013578","journal-title":"Drug Discov Today"},{"key":"9216_CR87","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.109.853069","volume":"121","author":"M Cattaneo","year":"2010","unstructured":"Cattaneo M (2010) New P2Y12 inhibitors. Circulation 121:171\u2013179","journal-title":"Circulation"},{"key":"9216_CR88","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1172\/JCI8399","volume":"104","author":"C Leon","year":"1999","unstructured":"Leon C, Hechler B, Freund M (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y receptor-null mice. J Clin Invest 104:1731\u20131737","journal-title":"J Clin Invest"},{"key":"9216_CR89","first-page":"133","volume":"13","author":"AM van Rhee","year":"1995","unstructured":"van Rhee AM, Fischer B, van Galen PJ, Jacobson KA (1995) Modelling the P2Y purinoceptor using rhodopsin as template. Drug Des Discov 13:133\u2013154","journal-title":"Drug Des Discov"},{"key":"9216_CR90","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1021\/jm010369e","volume":"45","author":"HS Kim","year":"2002","unstructured":"Kim HS, Ravi RG, Marquez VE, Maddileti S, Wihlborg A-K, Erlinge D, Malmsj\u00f6 M, Boyer JL, Harden TK, Jacobson KA (2002) Methanocarba modification of uracil and adenine nucleotides: high potency of northern ring conformation at P2Y1, P2Y2, or P2Y4 and P2Y11, but not P2Y6 receptors. J Med Chem 45:208\u2013218","journal-title":"J Med Chem"},{"key":"9216_CR91","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1021\/jm010538v","volume":"45","author":"RG Ravi","year":"2002","unstructured":"Ravi RG, Kim HS, Servos J, Zimmermann H, Lee K, Maddileti S, Boyer JL, Harden TK, Jacobson KA (2002) Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y1 receptor agonists. J Med Chem 45:2090\u20132100","journal-title":"J Med Chem"},{"key":"9216_CR92","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1124\/jpet.104.068650","volume":"311","author":"M Chhatriwala","year":"2004","unstructured":"Chhatriwala M, Ravi RG, Patel RI, Boyer JL, Jacobson KA, Harden TK (2004) Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analogue. J Pharmacol Exp Ther 311:1038\u20131043","journal-title":"J Pharmacol Exp Ther"},{"key":"9216_CR93","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ddr.10381","volume":"61","author":"PM Dunn","year":"2004","unstructured":"Dunn PM, Kim HS, Jacobson KA, Burnstock G (2004) Northern ring conformation of methanocarba-adenosine 5\u2032-triphosphate required for activation of P2X receptors. Drug Dev Res 61:227\u2013232","journal-title":"Drug Dev Res"},{"key":"9216_CR94","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1021\/jm00076a023","volume":"36","author":"B Fischer","year":"1993","unstructured":"Fischer B, Boyer JL, Hoyle CHV, Ziganshin AU, Brizzolara AL, Knight GE, Zimmet J, Burnstock G, Harden TK, Jacobson KA (1993) Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5\u2032-triphosphate. J Med Chem 36:3937\u20133946","journal-title":"J Med Chem"},{"key":"9216_CR95","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1042\/bj2910875","volume":"291","author":"G Cristalli","year":"1993","unstructured":"Cristalli G, Mills DC (1993) Identification of a receptor for ADP on blood platelets by photoaffinity labelling. Biochem J 291:875\u2013881","journal-title":"Biochem J"},{"key":"9216_CR96","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1021\/jm990156d","volume":"42","author":"E Halbfinger","year":"1999","unstructured":"Halbfinger E, Major DT, Ritzmann M, Ubl J, Reiser G, Boyer JL, Harden KT, Fischer B (1999) Molecular recognition of modified adenine nucleotides by the P2Y1-receptor. 1. A synthetic, biochemical, and NMR approach. J Med Chem 42:5325\u20135337","journal-title":"J Med Chem"},{"key":"9216_CR97","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1021\/jm020251d","volume":"45","author":"V Nahum","year":"2002","unstructured":"Nahum V, Zundorf G, Levesque SA, Beaudoin AR, Reiser G, Fischer B (2002) Adenosine 5\u2032-O-(1-boranotriphosphate) derivatives as novel P2Y1 receptor agonists. J Med Chem 45:5384\u20135396","journal-title":"J Med Chem"},{"key":"9216_CR98","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.ejmech.2008.07.015","volume":"44","author":"SE Eliahu","year":"2009","unstructured":"Eliahu SE, Camden J, Lecka J, Weisman GA, Sevigny J, Gelinas S, Fischer B (2009) Identification of hydrolytically stable and selective P2Y1 receptor agonists. Eur J Med Chem 44:1525\u20131536","journal-title":"Eur J Med Chem"},{"key":"9216_CR99","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1021\/jm100030u","volume":"53","author":"S Eliahu","year":"2010","unstructured":"Eliahu S, Mart\u00edn-Gil A, Perez de Lara MJ, Pintor J, Camden J, Weisman GA, Lecka J, S\u00e9vigny J, Fischer B (2010) 2-MeS-\u03b2, \u03b3-CCl2-ATP is a potent agent for reducing intraocular pressure. J Med Chem 53:3305\u20133319","journal-title":"J Med Chem"},{"key":"9216_CR100","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0014-2999(01)01401-7","volume":"430","author":"K Patel","year":"2001","unstructured":"Patel K, Barnes A, Camacho J, Paterson C, Boughtflower R, Cousens D, Marshall F (2001) Activity of diadenosine polyphophates at P2Y receptors stably expressed in 1321N1 cells. Eur J Pharmacol 430:203\u2013210","journal-title":"Eur J Pharmacol"},{"key":"9216_CR101","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.thromres.2009.11.006","volume":"125","author":"H Chang","year":"2010","unstructured":"Chang H, Yanachkov IB, Michelson AD, Li Y, Barnard MR, Wright GE, Frelinger AL 3rd (2010) Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors. Thromb Res 125:159\u2013165","journal-title":"Thromb Res"},{"key":"9216_CR102","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1021\/jm901621h","volume":"53","author":"S Eliahu","year":"2010","unstructured":"Eliahu S, Barr HM, Camden J, Weisman GA, Fischer B (2010) A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold. J Med Chem 53:2472\u20132481","journal-title":"J Med Chem"},{"key":"9216_CR103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2010.11.004","volume":"333","author":"AJ Gustafsson","year":"2010","unstructured":"Gustafsson AJ, Muraro L, Dahlberg C, Migaud M, Chevallier O, Khanh HN, Li N, Islam MS (2010) ADP ribose is an endogenous ligand for the purinergic P2Y1 receptor. Mol Cell Endocrinol 333:8\u201319","journal-title":"Mol Cell Endocrinol"},{"key":"9216_CR104","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ceca.2009.08.004","volume":"46","author":"C Klein","year":"2009","unstructured":"Klein C, Grahnert A, Abdelrahman A, M\u00fcller CE, Hauschildt S (2009) Extracellular NAD+ induces a rise in [Ca2+]i in activated human monocytes via engagement of P2Y1 and P2Y11 receptors. Cell Calcium 46:263\u2013272","journal-title":"Cell Calcium"},{"key":"9216_CR105","doi-asserted-by":"publisher","first-page":"16359","DOI":"10.1073\/pnas.0705510104","volume":"104","author":"VN Mutafova-Yambolieva","year":"2007","unstructured":"Mutafova-Yambolieva VN, Hwang SJ, Hao X, Chen H, Zhu MX, Wood JD, Ward SM, Sanders KM (2007) Beta-nicotinamide adenine dinucleotide is an inhibitory neurotransmitter in visceral smooth muscle. Proc Natl Acad Sci USA 104:16359\u201316364","journal-title":"Proc Natl Acad Sci USA"},{"key":"9216_CR106","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.bcp.2007.10.037","volume":"75","author":"ZG Gao","year":"2008","unstructured":"Gao ZG, Hechler B, Besada P, Gachet C, Jacobson KA (2008) Caged agonist of P2Y1 and P2Y12 receptors for light-directed facilitation of platelet aggregation. Biochem Pharmacol 75:1341\u20131347","journal-title":"Biochem Pharmacol"},{"key":"9216_CR107","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0026-895X(25)09561-6","volume":"50","author":"JL Boyer","year":"1996","unstructured":"Boyer JL, Romero-Avila T, Schachter JB, Harden TK (1996) Identification of competitive antagonists of the P2Y1-receptor. Mol Pharmacol 50:1323\u20131329","journal-title":"Mol Pharmacol"},{"key":"9216_CR108","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1021\/jm980657j","volume":"42","author":"E Nandanan","year":"1999","unstructured":"Nandanan E, Camaioni E, Jang SY, Kim Y-C, Cristalli G, Herdewijn P, Secrist JA, Tiwari KN, Mohanram A, Harden TK, Boyer JL, Jacobson KA (1999) Structure activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. J Med Chem 42:1625\u20131638","journal-title":"J Med Chem"},{"key":"9216_CR109","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0014-2999(01)00733-6","volume":"412","author":"A Baurand","year":"2001","unstructured":"Baurand A, Raboisson P, Freund M, L\u00e9on C, Cazenave JP, Bourguignon JJ, Gachet C (2001) Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol 412:213\u2013221","journal-title":"Eur J Pharmacol"},{"key":"9216_CR110","doi-asserted-by":"publisher","first-page":"8063","DOI":"10.1021\/jo026268l","volume":"67","author":"P Raboisson","year":"2002","unstructured":"Raboisson P, Baurand A, Cazenave JP, Gachet C, Schultz D, Spiess B, Bourguignon JJ (2002) A general approach toward the synthesis of C-nucleoside pyrazolo[1,5-a]-1, 3, 5-triazines and their 3\u2032,5\u2032-bisphosphate C-nucleotide analogues as the first reported in vivo stable P2Y1-receptor antagonists. J Org Chem 67:8063\u20138071","journal-title":"J Org Chem"},{"key":"9216_CR111","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1021\/jm030127+","volume":"46","author":"HS Kim","year":"2003","unstructured":"Kim HS, Ohno M, Xu B, Kim HO, Choi Y, Ji XD, Maddileti S, Marquez VE, Harden TK, Jacobson KA (2003) 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a Northern conformation: enhanced potency as P2Y1 receptor antagonists. J Med Chem 46:4974\u20134987","journal-title":"J Med Chem"},{"key":"9216_CR112","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.bcp.2004.06.026","volume":"68","author":"M Cattaneo","year":"2004","unstructured":"Cattaneo M, Lecchi A, Joshi BV, Ohno M, Besada P, Tchilibon S, Lombardi R, Bischofberger N, Harden TK, Jacobson KA (2004) Antiaggregatory activity in human platelets of potent antagonists of the P2Y1 receptor. Biochem Pharmacol 68:1995\u20132002","journal-title":"Biochem Pharmacol"},{"key":"9216_CR113","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1124\/jpet.105.094037","volume":"316","author":"B Hechler","year":"2006","unstructured":"Hechler B, Nonne C, Roh EJ, Cattaneo M, CazenaveFranc JP, Lanza F, Jacobson KA, Gachet C (2006) MRS2500 [2-iodo-N\n                           6-methyl-(N)-methanocarba-2\u2032-deoxyadenosine-3\u2032,5\u2032-bisphosphate], a potent, selective and stable antagonist of the P2Y1 receptor, with strong antithrombotic activity in mice. J Pharmacol Exp Ther 316:556\u2013563","journal-title":"J Pharmacol Exp Ther"},{"key":"9216_CR114","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1124\/mol.62.5.1249","volume":"62","author":"G Waldo","year":"2002","unstructured":"Waldo G, Corbitt J, Boyer JL, Ravi G, Kim HS, Ji X-D, Lacy J, Jacobson KA, Harden TK (2002) Quantitation of the P2Y1 receptor with a high affinity radiolabeled antagonist. Mol Pharmacol 62:1249\u20131257","journal-title":"Mol Pharmacol"},{"key":"9216_CR115","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.phrs.2010.05.007","volume":"62","author":"P Ohlmann","year":"2010","unstructured":"Ohlmann P, de Castro S, Brown GG, Gachet C, Jacobson KA, Harden TK (2010) Quantification of recombinant and platelet P2Y1 receptors utilizing a [125I]-labeled high affinity antagonist 2-iodo-N\n                           6-methyl-(N)-methanocarba-2\u2032-deoxyadenosine-3\u2032, 5\u2032-bisphosphate ([125I]MRS2500). Pharmacol Res 62:344\u2013351","journal-title":"Pharmacol Res"},{"key":"9216_CR116","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.1021\/jm020173u","volume":"45","author":"B Xu","year":"2002","unstructured":"Xu B, Stephens A, Kirschenheuter G, Greslin AF, Cheng X, Sennelo J, Cattaneo M, Zighetti ML, Chen A, Kim SA, Kim HS, Bischofberger N, Cook G, Jacobson KA (2002) Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation. J Med Chem 45:5694\u20135709","journal-title":"J Med Chem"},{"key":"9216_CR117","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1021\/jm0700971","volume":"50","author":"S Costanzi","year":"2007","unstructured":"Costanzi S, Tikhonova IG, Ohno M, Roh EJ, Joshi BV, Colson A-O, Houston D, Maddileti S, Harden TK, Jacobson KA (2007) P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoring. J Med Chem 50:3229\u20133241","journal-title":"J Med Chem"},{"key":"9216_CR118","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1021\/jm0493562","volume":"48","author":"G Cristalli","year":"2005","unstructured":"Cristalli G, Podda GM, Costanzi S, Lambertucci C, Lecchi A, Vittori S, Volpini R, Zighetti ML, Cattaneo M (2005) Effects of 5\u2032-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors. J Med Chem 48:2763\u20132766","journal-title":"J Med Chem"},{"key":"9216_CR119","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0014-5793(03)00044-9","volume":"536","author":"C Coddou","year":"2003","unstructured":"Coddou C, Loyola G, Boyer JL, Bronfman M, Huidobro-Toro JP (2003) The hypolipidemic drug metabolites nafenopin-CoA and ciprofibroyl-CoA are competitive P2Y1 receptor antagonists. FEBS Lett 536:145\u2013150","journal-title":"FEBS Lett"},{"key":"9216_CR120","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/09537100701708498","volume":"2","author":"P Manolopoulos","year":"2008","unstructured":"Manolopoulos P, Glenn JR, Fox SC, May JA, Dovlatova NL, Tang SW, Thomas NR, Ralevic V, Heptinstall S (2008) Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents. Platelets 2:134\u2013145","journal-title":"Platelets"},{"key":"9216_CR121","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bcp.2004.02.039","volume":"68","author":"ZG Gao","year":"2004","unstructured":"Gao ZG, Mamedova L, Tchilibon S, Gross AS, Jacobson KA (2004) 2,2\u2032-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding. Biochem Pharmacol 68:231\u2013237","journal-title":"Biochem Pharmacol"},{"key":"9216_CR122","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1016\/j.bmcl.2008.04.028","volume":"18","author":"JA Pfefferkorn","year":"2008","unstructured":"Pfefferkorn JA, Choi C, Winters T, Kennedy R, Chi L, Perrin LA, Lu G, Ping YW, McClanahan T, Schroeder R, Leininger MT, Geyer A, Schefzick S, Atherton J (2008) P2Y1 receptor antagonists as novel antithrombotic agents. Bioorg Med Chem Lett 18:3338\u20133343","journal-title":"Bioorg Med Chem Lett"},{"key":"9216_CR123","unstructured":"Herpin TF, Morton G, Rehfuss RP, Lawrence RM, Poss MA, Roberge JY, Gungor T (2005) Aminobenzazoles as P2Y1 receptors inhibitors. WO2005070920. August 4, 2005"},{"key":"9216_CR124","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1016\/j.bmcl.2008.09.102","volume":"18","author":"AI Morales-Ramos","year":"2008","unstructured":"Morales-Ramos AI, Mecom JS, Kiesow TJ, Graybill TL, Brown GD, Aiyar NV, Davenport EA, Kallal LA, Knapp-Reed BA, Li P, Londregan AT, Morrow DM, Senadhi S, Thalji RK, Zhao S, Burns-Kurtis CL, Marino JP Jr (2008) Tetrahydro-4-quinolinamines identified as novel P2Y1 receptor antagonists. Bioorg Med Chem Lett 18:6222\u20136226","journal-title":"Bioorg Med Chem Lett"},{"key":"9216_CR125","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1016\/j.bmcl.2010.05.072","volume":"20","author":"RK Thalji","year":"2010","unstructured":"Thalji RK, Aiyar NV, Davenport EA, Erhardt JA, Kallal LA, Morrow DM, Senadhi S, Burns-Kurtis CL, Marino JP Jr (2010) Benzofuran-substituted urea derivatives as novel P2Y1 receptor antagonists. Bioorg Med Chem Lett 20:4104\u20134107","journal-title":"Bioorg Med Chem Lett"},{"key":"9216_CR126","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.bmc.2003.12.041","volume":"12","author":"R Mathieu","year":"2004","unstructured":"Mathieu R, Baurand A, Schmitt M, Gachet C, Bourguignon JJ (2004) Synthesis and biological activity of 2-alkylated deoxyadenosine bisphosphate derivatives as P2Y1 receptor antagonists. Bioorg Med Chem 12:1769\u20131779","journal-title":"Bioorg Med Chem"},{"key":"9216_CR127","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1476-5381.1996.tb15630.x","volume":"118","author":"JL Boyer","year":"1996","unstructured":"Boyer JL, Siddiqi S, Fischer B, Romera-Avila T, Jacobson KA, Harden TK (1996) Identification of potent P2Y-purinoceptor agonists that are derivatives of adenosine 5\u2032-monophosphate. Br J Pharmacol 118:1959\u20131964","journal-title":"Br J Pharmacol"},{"key":"9216_CR128","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614133","volume":"84","author":"P Savi","year":"2002","unstructured":"Savi P, Pereillo JM, Uzabiaga MF, Combalbert J, Picard C, Maffrand JP, Pascal M, Herbert JM (2002) Identification and biological activity of the active metabolite of Clopidogrel. Thromb Haemost 84:891\u2013896","journal-title":"Thromb Haemost"},{"key":"9216_CR129","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/MOH.0b013e32832ea2f2","volume":"5","author":"AD Michelson","year":"2009","unstructured":"Michelson AD (2009) New P2Y12 antagonists. Curr Opin Hematol 5:371\u2013377","journal-title":"Curr Opin Hematol"},{"key":"9216_CR130","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-2125.2006.02792.x","volume":"63","author":"JA Jakubowski","year":"2007","unstructured":"Jakubowski JA, Matsushima N, Asai F, Naganuma H, Brandt JT, Hirota T, Freestone S, Winters KJ (2007) A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans. Br J Clin Pharmacol 63:421\u2013430","journal-title":"Br J Clin Pharmacol"},{"key":"9216_CR131","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1021\/jm981072s","volume":"42","author":"AH Ingall","year":"1999","unstructured":"Ingall AH, Dixon J, Bailey A, Coombs ME, McInally JI, Hunt SF, Kindon ND, Theobald BJ, Willis PA, Humphries R, Leff P, Clegg JA, Smith JA, Tomlinson W (1999) Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J Med Chem 42:213\u2013220","journal-title":"J Med Chem"},{"key":"9216_CR132","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1016\/j.bmcl.2007.07.057","volume":"17","author":"B Springthorpe","year":"2007","unstructured":"Springthorpe B, Bailey A, Barton P, Birkinshaw TN, Bonnert RV, Brown RC, Chapman D, Dixon J, Guile SD, Humphries RG, Hunt SF, Ince F, Ingall AH, Kirk IP, Leeson PD, Leff P, Lewis RJ, Martin BP, McGinnity DF, Mortimore MP, Paine SW, Pairaudeau G, Patel A, Rigby AJ, Riley RJ, Teobald BJ, Tomlinson W, Webborn PJ, Willis PA (2007) From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis. Bioorg Med Chem Lett 17:6013\u20136018","journal-title":"Bioorg Med Chem Lett"},{"key":"9216_CR133","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/09537100701268741","volume":"18","author":"FL Johnson","year":"2007","unstructured":"Johnson FL, Boyer JL, Leese PT, Crean C, Krishnamoorthy R, Durham T, Fox AW, Kellerman DJ (2007) Rapid and reversible modulation of platelet function in man by a novel P2Y12 ADP-receptor antagonist, INS50589. Platelets 18:346\u2013356","journal-title":"Platelets"},{"key":"9216_CR134","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1021\/jm701348d","volume":"51","author":"J Douglass","year":"2008","unstructured":"Douglass J, Patel RI, Yerxa B, Shaver SR, Watson PS, Bednarski K, Plourde R, Redick C, Brubaker K, Jones AC, Boyer JL (2008) Lipophilic modifications to dinucleoside polyphosphates and nucleotides that confer antagonist properties at the P2Y12 platelet receptor. J Med Chem 51:1007\u20131025","journal-title":"J Med Chem"},{"key":"9216_CR135","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1755-5922.2009.00096.x","volume":"27","author":"S Husted","year":"2009","unstructured":"Husted S, van Giezen JJ (2009) Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist. Cardiovasc Ther 27:259\u2013274","journal-title":"Cardiovasc Ther"},{"key":"9216_CR136","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.thromres.2009.06.029","volume":"124","author":"JJ Van Giezen","year":"2009","unstructured":"Van Giezen JJ, Berntsson P, Zachrisson H, Bj\u00f6rkman JA (2009) Comparison of ticagrelor and thienopyridine P2Y12 binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis\/hemostasis. Thromb Res 124:565\u2013571","journal-title":"Thromb Res"},{"key":"9216_CR137","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/cmdc.200700310","volume":"3","author":"H Ye","year":"2003","unstructured":"Ye H, Chen C, Zhang HC, Haertlein BJ, Parry TJ, Damiano BP, Maryanoff BE (2003) Carba-nucleosides as potent antagonists of the adenosine 5\u2032-diphosphate (ADP) purinergic receptor (P2Y12) on human platelets. ChemMed Chem 3:732\u2013736","journal-title":"ChemMed Chem"},{"key":"9216_CR138","first-page":"340","volume":"11","author":"JH Oestereich","year":"2010","unstructured":"Oestereich JH (2010) Elinogrel, a reversible P2Y12 antagonist for the treatment of acutre coronary syndrome and prevention of secondary thrombotic events. Curr Opin Investig Drugs 11:340\u2013348","journal-title":"Curr Opin Investig Drugs"},{"key":"9216_CR139","unstructured":"Fretz H, Houille O, Hilpert K, Peter O, Breu V, Giller T, Valdenaire O, Riederer M (2005) Novel pyrazolidine-3,5-dione derivatives are P2Y12 receptor antagonists and inhibit ADP-triggered blood platelet aggregation. 229th National Meeting of the American Chemical Soc, San Diego, CA, Abstract MEDI 80"},{"key":"9216_CR140","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0960-894X(01)00313-4","volume":"11","author":"RM Scarborough","year":"2001","unstructured":"Scarborough RM, Laibelman AM, Clizbe LA, Fretto LJ, Conley PB, Reynolds E, Sedlock M, Jantzen H-M (2001) Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y12). Bioorg Med Chem Lett 11:1805\u20131808","journal-title":"Bioorg Med Chem Lett"},{"key":"9216_CR141","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1160\/TH06-12-0732","volume":"97","author":"YX Wang","year":"2007","unstructured":"Wang YX, Vincelette J, da Cunha V, Martin-McNulty B, Mallari C, Fitch RM, Alexander S, Islam I, Buckman BO, Yuan S, Post JM, Subramanyam B, Vergona R, Sullivan ME, Dole WP, Morser J, Bryant J (2007) A novel P2Y12 adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models. Thromb Haemost 97:847\u2013855","journal-title":"Thromb Haemost"},{"key":"9216_CR142","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.thromres.2008.03.026","volume":"4","author":"J Bryant","year":"2008","unstructured":"Bryant J, Post JM, Alexander S, Wang YX, Kent L, Schirm S, Tseng JL, Subramanyam B, Buckman B, Islam I, Yuan S, Sullivan ME, Snider M, Morser J (2008) Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets. Thromb Res 4:523\u2013532","journal-title":"Thromb Res"},{"key":"9216_CR143","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1016\/j.bmcl.2009.06.075","volume":"16","author":"JJ Parlow","year":"2009","unstructured":"Parlow JJ, Burney MW, Case BL, Girard TJ, Hall KA, Hiebsch RR, Huff RM, Lachance RM, Mischke DA, Rapp SR, Woerndle RS, Ennis MD (2009) Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation. Bioorg Med Chem Lett 16:4657\u20134663","journal-title":"Bioorg Med Chem Lett"},{"key":"9216_CR144","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.bmcl.2009.12.110","volume":"20","author":"JJ Parlow","year":"2010","unstructured":"Parlow JJ, Burney MW, Case BL, Girard TJ, Hall KA, Harris PK, Hiebsch RR, Huff RM, Lachance RM, Mischke DA, Rapp SR, Woerndle RS, Ennis MD (2010) Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation. Bioorg Med Chem Lett 20:1388\u20131394","journal-title":"Bioorg Med Chem Lett"},{"key":"9216_CR145","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1021\/jm901518t","volume":"53","author":"JJ Parlow","year":"2010","unstructured":"Parlow JJ, Burney MW, Case BL, Girard TJ, Hall KA, Harris PK, Hiebsch RR, Huff RM, Lachance RM, Mischke DA, Rapp SR, Woerndle RS, Ennis MD (2010) Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation. J Med Chem 53:2010\u20132037","journal-title":"J Med Chem"},{"key":"9216_CR146","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1016\/j.bmc.2009.04.061","volume":"17","author":"P Crepaldi","year":"2009","unstructured":"Crepaldi P, Cacciari B, Bonache MC, Spalluto G, Varani K, Borea PA, K\u00fcgelgen I, Hoffmann K, Pugliano M, Razzari C, Cattaneo M (2009) 6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors. Bioorg Med Chem 17:4612\u20134621","journal-title":"Bioorg Med Chem"},{"key":"9216_CR147","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1021\/jm9003297","volume":"52","author":"Y Baqi","year":"2009","unstructured":"Baqi Y, Atzler K, K\u00f6se M, Gl\u00e4nzel M, M\u00fcller CE (2009) High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors. J Med Chem 52:3784\u20133793","journal-title":"J Med Chem"},{"key":"9216_CR148","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1160\/TH10-05-0285","volume":"104","author":"S Zhang","year":"2010","unstructured":"Zhang S, Hu L, Du H, Guo Y, Zhang Y, Niu H, Jin J, Zhang J, Liu J, Zhang X, Kunapuli SP, Ding Z (2010) BF0801, a novel adenine derivative, inhibits platelet activation via phosphodiesterase inhibition and P2Y12 antagonism. Thromb Haemost 104:845\u2013857","journal-title":"Thromb Haemost"},{"key":"9216_CR149","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1021\/jm901432g","volume":"53","author":"A Das","year":"2010","unstructured":"Das A, Ko H, Burianek LE, Barrett MO, Harden TK, Jacobson KA (2010) Human P2Y14 receptor agonists: truncation of the hexose moiety of uridine-5\u2032-diphosphoglucose and its replacement with alkyl and aryl groups. J Med Chem 53:471\u2013480","journal-title":"J Med Chem"},{"key":"9216_CR150","unstructured":"International Patent Application No. PCT\/CA2008\/002105, WO 2009\/070873 A1 (published June 11, 2009), Merck Frosst Canada Ltd., applicant"},{"key":"9216_CR151","unstructured":"International Patent Application No. PCT\/CA2008\/001214, WO2009\/000087 A1 (published Dec. 31, 2008), Merck Frosst Canada Ltd., applicant"},{"key":"9216_CR152","doi-asserted-by":"crossref","unstructured":"Robichaud J, Fournier J-F, Gagn\u00e9 S, Gauthier JY, Hamel M, Han Y, H\u00e9nault M, Kargman S, Levesque J-F, Mamane Y, Mancini J, Morin N, Mulrooney E, Wu J, Black WC (2011) Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y14. Bioorg Med Chem Lett. doi:10.1016\/j.bmcl.2010.12.113","DOI":"10.1016\/j.bmcl.2010.12.113"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-011-9216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-011-9216-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-011-9216-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-011-9216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:37:34Z","timestamp":1744169854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-011-9216-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,18]]},"references-count":152,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["9216"],"URL":"https:\/\/doi.org\/10.1007\/s11302-011-9216-0","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,18]]},"assertion":[{"value":"14 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}